ESR2 and breast carcinoma: Thus, by acting as an AI that also modulates ERα, ERβ and AR, Oxy impaired cancer cell growth by disrupting cell cycle and DNA synthesis, and induced apoptosis of sensitive ER+ breast cancer cells.